150 results on '"Marayati, Raoud"'
Search Results
2. PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4
3. Serine-Threonine Kinase Receptor Associate Protein (STRAP) confers an aggressive phenotype in neuroblastoma via regulation of Focal Adhesion Kinase (FAK)
4. Metastatic human hepatoblastoma cells exhibit enhanced tumorigenicity, invasiveness and a stem cell-like phenotype
5. CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells
6. Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like Tumor
7. PIM447 inhibits oncogenesis and potentiates cisplatin effects in hepatoblastoma
8. Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenografts
9. 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts
10. Novel PP2A-Activating Compounds in Neuroblastoma.
11. Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma
12. The Role and Efficacy of Laboratories in the Diagnosis of Pediatric Appendicitis
13. UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts
14. Pentalogy of Cantrell
15. PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma
16. PIM Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma
17. Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression
18. Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts
19. PIM Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma.
20. Rapid Characterization of Solid Tumors Using Resonant Sensors
21. The Role of PIM Kinases in Pediatric Solid Tumors
22. Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
23. Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy
24. Metastatic Hepatoblastoma Cells Exhibit a Distinct Cancer Stem Cell-Like Phenotype
25. Serine-Threonine Kinase Receptor Associated Protein Confers Aggressive Phenotype in Neuroblastoma Via Regulation of Focal Adhesion Kinase Signaling
26. Establishing a Novel 3-Dimensional Printing Model to Study Pediatric Solid Tumors
27. Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines
28. Preclinical evaluation of an engineered oncolytic herpes simplex virus for pediatric osteosarcoma.
29. CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells
30. EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth
31. Novel Second Generation Rexinoid Induces Growth Arrest and Reduces Cancer Cell Stemness in Human Neuroblastoma Patient-Derived Xenografts
32. PIM Kinase Inhibitor, PIM447, Decreases Cancer Cell Stemness And Exhibits Synergy With Cisplatin In Hepatoblastoma
33. Serine-Threonine Kinase Receptor Associate Protein (STRAP) Confers Stemness in Neuroblastoma
34. Novel Second-Generation Rexinoid Reduces Cancer Cell Stemness in Human Neuroblastoma Patient-Derived Xenografts
35. MEK1/2 Inhibition as a Therapeutic Target in an NRAS-Mutated Pediatric Neuroendocrine Tumor
36. Serine-Threonine Kinase Receptor Associate Protein Confers Stemness in Neuroblastoma
37. PIM Kinase Inhibitor, PIM447, Decreases Oncogenicity and Cancer Cell Stemness in a Human Hepatoblastoma Patient-Derived Xenograft
38. Novel Retinoic Acid Derivative Induces Differentiation and Growth Arrest in Neuroblastoma
39. Novel therapeutics in hepatoblastoma
40. Immunotherapy in Pediatric Solid Tumors—A Systematic Review
41. Novel Retinoic Acid Derivative Induces Differentiation and Growth Arrest in Neuroblastoma
42. Anaplastic Lymphoma Kinase Inhibition Decreases Tumor Growth in a TYRO3-Mutated Tumor Through Downregulation of STAT3 Signaling
43. The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor
44. PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells
45. Preclinical evidence for employing MEK inhibition in NRASmutated pediatric gastroenteropancreatic neuroendocrine-like tumors
46. Long-Term ERK Inhibition in
47. Selective single cell isolation for genomics using microraft arrays
48. Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer
49. Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts
50. Differentially expressed gene signature associated with metastasis and poor outcome in pancreatic cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.